Jazz Pharma to Pay $145 Million to Settle Narcolepsy Drug Antitrust Case
Insurance Journal - Apr 09, 2025
Jazz Pharmaceuticals JAZZ.O said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem. Xyrem, a medication approved in the U.S., is used for the …...
Recommended Articles
Posted: Jul 21, 2025
Uber Technologies Inc. is suing a group of lawyers and medical providers in Los Angeles who it says...
Posted: Jul 21, 2025
Here are the details of the European Union’s 18th package of sanctions against Russia over its...
Posted: Jul 21, 2025
A Bettendorf, Iowa insurance public adjuster has been charged with forgery and identity theft, the I...